NasdaqCM - Delayed Quote USD
Viking Therapeutics, Inc. (VKTX)
25.48
+1.76
+(7.42%)
At close: April 22 at 4:00:01 PM EDT
25.91
+0.43
+(1.68%)
After hours: April 22 at 7:56:15 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-87,790
-87,790
-73,376
-48,397
-47,586
Investing Cash Flow
-553,366
-553,366
-179,086
54,753
37,960
Financing Cash Flow
612,464
612,464
271,376
4,163
6,880
End Cash Position
26,676
26,676
55,516
36,632
26,371
Issuance of Capital Stock
597,094
597,094
269,760
--
--
Repurchase of Capital Stock
--
--
--
-6,817
--
Free Cash Flow
-87,790
-87,790
-73,376
-48,397
-47,586
12/31/2021 - 4/28/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GPCR Structure Therapeutics Inc.
23.04
-0.26%
SMMT Summit Therapeutics Inc.
27.35
+8.45%
IOVA Iovance Biotherapeutics, Inc.
3.2100
+4.22%
MDGL Madrigal Pharmaceuticals, Inc.
302.72
+2.61%
QURE uniQure N.V.
14.39
+8.28%
VERV Verve Therapeutics, Inc.
5.25
+9.83%
MURA Mural Oncology plc
2.7200
+1.12%
ALT Altimmune, Inc.
4.8500
+1.25%
CRSP CRISPR Therapeutics AG
39.23
+3.73%
RXRX Recursion Pharmaceuticals, Inc.
5.63
+4.07%